Caricamento...
Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin
BACKGROUND: Pregabalin is an α(2)δ ligand indicated in the USA for treatment of a number of chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, pain associated with spinal cord injury, and fibromyalgia. A greater understanding of when patients first respond to...
Salvato in:
| Pubblicato in: | J Pain Res |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494606/ https://ncbi.nlm.nih.gov/pubmed/26170712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S82806 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|